1. Activity of Tagetes minuta Linnaeus (Asteraceae) essential oil against L3 Anisakis larvae type 1
Filippo GIARRATANA ; Daniele MUSCOLINO ; Graziella ZIINO ; Alessandro GIUFFRIDA ; Stefania Maria MAROTTA ; Vittorio LO PRESTI ; Vincenzo CHIOFALO ; Antonio PANEBIANCO
Asian Pacific Journal of Tropical Medicine 2017;10(5):461-465
Objective To evaluate in vitro effects of Tagetes minuta L. essential oil (TEO) on L3 Anisakis larvae type 1. Methods In order to evaluate the potential use of Tagetes minuta essential oil against L3 Anisakis larvae three different media were tested: 1) a saline solution (SS); 2) an industrial marinating solution (MS); 3) sunflower seeds oil (SO). For each media and concentrations of TEO (0.1%, 0.5%, 1.0% and 5.0% v/v), 20 parasites were introduced into plastic Petri dishes (diameter 90 mm) and maintained at room temperature. As controls, larvae were maintained without TEO under identical experimental conditions in SS, MS and SO. A total of 900 larvae were tested. The normalized mean viability, LT100, LT50 and the percentage of inactivation at 24 h were calculated. Results In vitro tests revealed a complete inactivation of parasites in saline solution after 2 h with 5% and 1% of TEO. In marinating solution, a complete inactivation of parasites was observed after 4 h at all concentrations used. A slower activity for all TEO concentration was reported in SO. Conclusions The results obtained, showing a strong activity against Anisakis larvae, confirm TEO as a larvicidal agent in the treatment of human anisakidosis and in the industrial marinating process.
2. Genetic diversity in Ebola virus: Phylogenetic and in silico structural studies of Ebola viral proteins
Alba GRIFONI ; Massimo AMICOSANTE ; Alessandra LO PRESTI ; Marta GIOVANETTI ; Eleonora CELLA ; Massimo CICCOZZI ; Marta GIOVANETTI ; Carla MONTESANO ; Vittorio COLIZZI ; Massimo AMICOSANTE ; Alessia LAI ; Gianguglielmo ZEHENDER ; Eleonora CELLA ; Silvia ANGELETTI ; Massimo CICCOZZI
Asian Pacific Journal of Tropical Medicine 2016;9(4):337-343
Objective: To explore the genetic diversity and the modification of antibody response in the recent outbreak of Ebola Virus. Methods: Sequences retrieved from public databases, the selective pressure analysis and the homology modeling based on the all protein (nucleoprotein, VP35, VP40, soluble glycoprotein, small soluble glycoprotein, VP30, VP24 and polymerase) were used. Results: Structural proteins VP24, VP30, VP35 and VP40 showed relative conserved sequences making them suitable target candidates for antiviral treatment. On the contrary, nucleoprotein, polymerase and soluble glycoprotein have high mutation frequency. Conclusions: Data from this study point out important aspects of Ebola virus sequence variability that for epitope and vaccine design should be considered for appropriate targeting of conserved protein regions.